SCHEMBL21775436

SCHEMBL21775436

CCCc1c(C)nc2cc(-c3ccc(Cl)cc3)nn2c1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.54
RAB9A P51151 1/20 0.54
DPP4 P27487 5/20 0.53
DPP8 Q6V1X1 3/20 0.53
MAPT P10636 6/20 0.50
ALDH1A1 P00352 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
HPGD P15428 2/20 0.50
LMNA P02545 1/20 0.50
GAA P10253 1/20 0.50
MAPK1 P28482 1/20 0.50
KDM4E B2RXH2 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
KMT2A Q03164 1/20 0.47
TP53 P04637 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
DPP9 Q86TI2 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21775454 0.90 NPC1 (0.57) NPC1RAB9ADPP4DPP8MAPT
SCHEMBL21775735 0.87 NPC1 (0.51) NPC1RAB9ADPP4DPP8MAPT
SCHEMBL21775858 0.84 NPC1 (0.53) NPC1RAB9ADPP4DPP8MAPT
SCHEMBL21775483 0.83 NPC1 (0.52) NPC1RAB9ADPP4DPP8MAPT
SCHEMBL21775855 0.82 NPC1 (0.51) NPC1RAB9ADPP4DPP8MAPT
SCHEMBL21775737 0.81 NPC1 (0.62) NPC1RAB9ADPP4DPP8MAPT
SCHEMBL21775736 0.79 NPC1 (0.53) NPC1RAB9ADPP4DPP8MAPT
SCHEMBL21775722 0.77 NPC1 (0.57) NPC1RAB9ADPP4DPP8MAPT
SCHEMBL21775509 0.77 NPC1 (0.57) NPC1RAB9ADPP4DPP8MAPT
SCHEMBL21749178 0.77 NPC1 (0.57) NPC1RAB9ADPP4DPP8MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives RICHTER GEDEON NYRT. (HU) 2021-03-30 US disclosed
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives RICHTER GEDEON NYRT. (HU) 2020-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives GABRA5, P2RX5, P2RY1 NPC1 1179/4885RAB9A 988/4885DPP4 721/4885
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives GABRA5, P2RX5, P2RY1 NPC1 1179/4885RAB9A 988/4885DPP4 721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.